Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat neovascular age-related macular degeneration (nAMD), dubbed HG202, developed using machine learning and AI.
The company used its HG-PRECISE platform (HuidaGene – Platform for Rational Engineering of...
Mark Cuban says it is vital for government officials to consider and understand the hierarchy when it comes to the prescription drug market and evaluating and setting laws around drug pricing.
"To me, it's all about transparency. In the drug market, and across healthcare, the opacity allows the biggest players to influence pricing and effectively find arbitrage points," Cuban told MobiHealthNews...
Qure.ai nets $65M for foundational AI
Qure.ai has raised $65 million in a Series D funding round led by Lightspeed and 360 ONE Asset.
The company said it will use its fresh funds to invest more in foundational AI models, as well as acquire complementary startups in medical technology. It will also be used to accelerate its expansion in the United States and other markets.
Early this year, the...
Pharmaceutical company Roche announced the expansion of its digital pathology open environment by integrating more than 20 advanced artificial intelligence algorithms from eight new collaborators.
The alliances aim to support pathologists and scientists in cancer research and diagnosis by leveraging AI.
The pharma giant will integrate the third-party AI tools into its navify Digital Pathology...
Google DeepMind announced the launch of AlphaProteo, an AI system to help biological and health researchers design novel, high-strength proteins that bind to target molecules with accuracy and strength.
AlphaProteo was trained on the Protein Data Bank (PDB) that enables breakthroughs in science and education by providing access and tools for exploration, visualization and analysis of...
AI and RNA genetic-medicine company Genetic Leap is teaming up with pharma giant Eli Lilly to develop genetic medicine therapeutics.
According to the two companies, the partnership expands on a pilot program utilizing Genetic Leap's RNA-targeted AI platform, designed to produce oligonucleotide drugs counter to targets chosen by Lilly in crucial therapeutic areas.
Lilly will provide Genetic Leap...
The Institute of Advanced Study in Science and Technology, an independent research institute under India's Department of Science and Technology, has invented a smartphone and sensor-based system to support the management of Parkinson's disease.
HOW IT WORKS
The system involves a fluorescence nanoprobe, a smartphone camera, and a mobile app. It aims to detect the concentration of L-dopa (levodopa...
Quest Diagnostics, a provider of diagnostic information services, announced it has acquired LifeLabs, a provider of laboratory diagnostic information and digital health connectivity systems, from benefit pension plan company OMERS in a deal valued at approximately CAN $1.35 billion (USD $1 billion).
LifeLabs will continue to operate under its own brand with the same management team at its Toronto...
Pharma companies are seeing the value of digital health, and are creating departments focused on developing, scaling and investing in platforms that use technology to enhance life sciences R&D, better assist providers and engage with patients.
Sonny Shergill, vice president of commercial digital health at AstraZeneca, sat down with MobiHealthNews to discuss the evolution of its strategy...
The EU AI Act comes into effect today, outlining regulations for the development, market placement, implementation and use of artificial intelligence in the European Union.
The Council wrote that the Act is intended to "promote the uptake of human-centric and trustworthy artificial intelligence while ensuring a high level of protection of health, safety, [and] fundamental rights … including...
